Filing Details
- Accession Number:
- 0001574774-18-000056
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-02 16:23:57
- Reporting Period:
- 2018-09-28
- Accepted Time:
- 2018-10-02 16:23:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1574774 | Biotelemetry Inc. | BEAT | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1557180 | Fred Broadway | 1000 Cedar Hollow Rd. Suite 102 Malvern PA 19355 | President Biotel Heart | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-09-28 | 39,238 | $4.67 | 64,118 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2018-09-28 | 26,963 | $2.80 | 91,081 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2018-09-28 | 23,912 | $2.54 | 114,993 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-09-28 | 90,113 | $65.00 | 24,880 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2018-09-28 | 39,238 | $0.00 | 39,238 | $4.67 |
Common Stock | Stock Options (Right to Buy) | Disposition | 2018-09-28 | 26,963 | $0.00 | 26,963 | $2.80 |
Common Stock | Stock Options (Right to Buy) | Disposition | 2018-09-28 | 23,912 | $0.00 | 23,912 | $2.54 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2021-03-04 | No | 4 | M | Direct | |
0 | 2022-02-21 | No | 4 | M | Direct | |
0 | 2023-02-19 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018.
- The options were fully exercisable on December 31, 2014.
- The options were fully exercisable on December 31, 2015.
- The options were fully exercisable on February 19, 2017.